Gary Lewis McPhail, MD
- Clinical Medical Director, Pulmonary Ambulatory Services, Division of Pulmonary Medicine
- Director, Cystic Fibrosis Research TDC Site, Division of Pulmonary Medicine
- Professor, UC Department of Pediatrics
- gary.mcphail@cchmc.org
- Board Certified
About
Biography
As a lung doctor (pulmonologist), I treat children and adolescents who have cystic fibrosis and chest wall disorders. I’m also a sleep medicine specialist, and I treat patients who have many types of sleep disorders.
I was drawn to my area of medicine by the great mentors I had in pediatric pulmonology, both in medical school and residency. Pediatric pulmonology provides the opportunity to do research, procedures, inpatient care and outpatient care. In addition, working with children and families is amazing and very rewarding.
My training in pediatric pulmonology and sleep medicine allows me to provide care for a wide range of childhood breathing concerns. We have clinics available at multiple Cincinnati Children's outpatient campuses, and we also serve patients via telemedicine. I enjoy doing telemedicine visits, since it allows me to learn new technology while providing convenience for families.
I provide family-centered and personalized care options to help children with medical concerns. Each child is unique, and families deserve choices. They are true partners in their child's care.
In 2016, I was honored to win the HOPE Award for Provider of Excellence from Department of Orthopaedics for my work in the Chest Wall Disorders Clinic. From 2014 to 2016, I was named one of Cincinnati Magazine's Top Doctors.
I direct cystic fibrosis clinical trials, with a focus on therapeutic trials of CFTR modulators that improve function of the cystic fibrosis protein in patients. Mutations in the CFTR gene inhibit it from performing its function, and can result in cystic fibrosis.
In my free time, my six children keep me busy.
MD: University of Texas Southwestern Medical Center, Dallas TX, 2001.
Residency: Children's Medical Center, University of Texas Southwestern, Dallas, TX, 2004.
Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2007.
Certification: Pediatrics, 2004; Pediatric Pulmonary, 2008.
Interests
Medical education; outcomes research; quality improvement; sleep medicine; thoracic insufficiency syndrome
Services and Specialties
Pulmonary Medicine, Sleep Disorders, Home Ventilator, Cystic Fibrosis
Interests
Medical education; pulmonary vascular disease; thoracic insufficiency syndrome
Research Areas
Pulmonary Medicine
Locations (2)
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials. The Lancet Respiratory Medicine. 2023; 11:329-340.
Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial. Thorax. 2022; 77:581-588.
Pharmacokinetic modelling to predict risk of ototoxicity with intravenous tobramycin treatment in cystic fibrosis. Journal of Antimicrobial Chemotherapy. 2021; 76:2923-2931.
Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort. American Journal of Audiology: a journal of clinical practice. 2021; 30:834-853.
Patient personalized translational tools in cystic fibrosis to transform data from bench to bed-side and back. American Journal of Physiology: Gastrointestinal and Liver Physiology. 2021; 320:G1123-G1130.
Characterization of tracheobronchomalacia in infants with hypophosphatasia. Orphanet Journal of Rare Diseases. 2020; 15:204.
Technology-Enabled Health Care Collaboration in Pediatric Chronic Illness: Pre-Post Interventional Study for Feasibility, Acceptability, and Clinical Impact of an Electronic Health Record-Linked Platform for Patient-Clinician Partnership. JMIR mHealth and uHealth. 2020; 8:e11968.
Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial. The Lancet Respiratory Medicine. 2019; 7:802-809.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2024 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey